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Summary 
Periodontitis is a chronic inflammatory disease caused by the colonisation of teeth by the 
bacterial plaque biofilm and the resultant host immune responses in adjacent periodontal 
tissues. Disease severity can vary dramatically between patients with periodontitis, with some 
subjects displaying inflammation without bony destruction (gingivitis), whilst others 
experience chronic progressive or rapidly aggressive gingival connective tissue damage and 
bone loss. To determine whether peripheral immune dysregulation is associated with 
periodontitis, we performed extensive analysis of immune cell subsets in peripheral blood 
from patients with chronic or aggressive periodontitis vs. periodontally healthy control 
subjects. Peripheral blood mononuclear cells (PBMC) from patients with chronic 
periodontitis or aggressive periodontitis and from periodontally healthy controls were 
analysed by 8-10 colour flow cytometry for the frequencies of various lymphocyte subsets, 
including IL-17, IFNγ, TNFα and IL-10 producing cells, and the frequencies and phenotype 
of monocytes. Cytokine levels in serum from the different groups were determined by 
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Luminex assay. We found no significant differences in the frequencies of major immune cell 
populations (CD4+ T cells, CD8+ T cells,  T cells, CD4+CD45RO+CD25+CD127low 
regulatory T cells (Tregs), CD19+ B cells, CD14+ monocytes) or of cytokine producing T 
cells, or in the phenotype of CD14+ monocytes in peripheral blood from these patient 
cohorts. Additionally, no significant differences were observed in serum levels of 
prototypical inflammatory cytokines. These results suggest that the local gingival 
inflammatory response is not reflected by obvious changes in major blood immune cell 
subset frequencies. 
 
Introduction 
Periodontitis is a chronic inflammatory disease caused by the colonisation of teeth by the 
bacterial plaque biofilm and the resultant host immune responses that occur in the 
surrounding periodontal tissues. The bacterial plaque biofilm induces an inflammatory 
infiltrate in periodontal tissue, in which the dominant immune cell populations may differ 
from person to person. There are wide variations in disease severity between patients with 
periodontal disease. Many subjects will have superficial gingival inflammation without any 
deeper tissue destruction, (gingivitis), whilst other subjects will experience progressive 
destruction of the supporting tissues of the tooth, including connective tissue damage and loss 
of alveolar bone (periodontitis). In the majority of cases progression of tissue damage occurs 
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slowly over many years and is affected by risk factors, such as oral hygiene and plaque 
levels, local predisposing factors, smoking, genetic factors, systemic risk factors such as 
diabetes and stress (Chronic Periodontitis). In a smaller number of cases tissue damage may 
occur rapidly, typically with an early age of onset (<35 years), and may result in rapid tooth 
loss (Aggressive Periodontitis) [1].  
 
    Studies have shown increased levels of pro-inflammatory cytokines such as IL-17 in 
serum from patients with periodontitis when compared to healthy controls [2-4]. 
Furthermore, studies have reported a decreased percentage of IL-17+ CD4+ T cells in 
peripheral blood mononuclear cells (PBMC) as well as decreased levels of IL-17 protein in 
serum from patients with periodontitis following non-surgical periodontal treatment [5-7]. 
These findings suggest that changes in cytokine levels in locally inflamed gingival tissue are 
mirrored by cytokine levels in the systemic circulation. Other studies have determined the 
frequencies of immune cell populations and cytokine producing T helper cells in peripheral 
blood from patients with different forms of periodontitis, i.e. chronic and aggressive 
periodontitis [8-10]. However, the limited existing data regarding IFNγ, IL-4 or IL-17 
producing cells in peripheral blood are not definitive as both decreased and increased 
percentages of these cytokine-expressing cells in PBMC from patients with periodontitis have 
been demonstrated relative to healthy controls [8-10]. The conflicting conclusions from these 
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studies may be because different classifications of periodontitis were utilised (e.g. differences 
in the number of teeth affected, or different age criteria for chronic or acute periodontitis), or 
because not all studies included patients with different forms of periodontitis.  
 
Studies have suggested that monocytes during or after periodontal pathogen challenge 
could contribute to inflammation in periodontitis-associated systemic disease such as aortic 
inflammation [11, 12]. One study has shown an increased percentage of CD14+CD16+ 
monocytes in the peripheral blood of patients with chronic periodontitis compared to healthy 
individuals [13], but overall data on peripheral blood monocyte populations in periodontitis 
are scarce.  
 
    Epidemiological data suggest an association between periodontal diseases and systemic 
conditions such as atherosclerotic cardiovascular disease, an increased risk of preterm low 
birth-weight babies, and chronic inflammatory diseases such as rheumatoid arthritis, diabetes 
and respiratory diseases, although the mechanisms for the various relationships remain 
largely unknown (reviewed in [14, 15]). A possible mechanism has been established by 
which locally produced pro-inflammatory cytokines including IL-6, IL-1β and TNFα in 
severe periodontitis can enter the systemic circulation and cause increases in the serum levels 
of these cytokines as well as elevated levels of C-reactive protein (reviewed in [14]).  
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To assess the effect of localised inflamed tissue on the systemic circulation in 
periodontitis, we performed a systematic analysis of immune cell subsets in peripheral blood 
from patients with chronic or aggressive periodontitis and periodontally healthy control 
subjects. Specifically, we investigated the frequencies of the main immune cell subsets (T 
cells, Tregs, B cells, monocytes, NK cells), and frequencies of IL-17, IFNγ, TNFα and IL-10 
producing cells within CD4+ T cells, CD8+ T cells, γδ T cells and CD19+ B cells. We 
focused on these four cytokines as they are important in regulation of inflammation-induced 
tissue destruction in periodontitis. Furthermore, we investigated the phenotype of peripheral 
blood CD14+ monocytes, and also determined the levels of a wide range of T cell-derived or 
monocyte-derived cytokines in the serum from patients with periodontitis and periodontally 
healthy controls. Overall our data do not indicate significant changes in any of these 
parameters.   
 
Materials and Methods 
Patient and healthy control samples 
Healthy control samples were obtained from periodontally healthy volunteers. Newly 
diagnosed patients with periodontitis were recruited from the periodontal clinic at Guy’s 
Hospital (see Table I for clinical and demographic parameters). Fifty ml of peripheral venous 
blood was drawn from each participant from the antecubital fossa and collected in Sodium 
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Heparin Plasma tubes (BD, Franklin Lakes, NJ, USA). An additional 6 ml of blood was 
collected in anticoagulant-free serum tubes (BD) and stored at 4°C (fridge) for 1 hour before 
centrifugation at 1200 rpm for 10 minutes and harvesting of the serum. The harvested serum 
samples were aliquoted into 500 μl amounts and stored at -80°C until further analysis. Oral 
and periodontal examination records, age, sex and smoking status were documented on the 
day of sample collection. Periodontal disease case definitions for chronic periodontitis were 
used according to those described by Page and Eke, and definitions for aggressive 
periodontitis according to those proposed by Demmer and Papapanou [16, 17], with the 
presence of two or more interproximal, nonadjacent sites with attachment loss of ≥ 6 mm 
occurring at a minimum of two different teeth and accompanied by bleeding on probing. Age 
and sex matched periodontally healthy control subjects were recruited and assessed with 
definitions as no probing pocket depth (PPD) >3 mm at any site, no proximal sites with 
attachment loss at any site, and BOP of < 20% of possible sites. All clinical investigations 
were conducted according to the Declaration of Helsinki principles. Ethics approval for this 
study was given by the NRES Committee London City Road & Hampstead Research Ethics 
Committee (12/LO/0376). Written informed consent was received from participants before 
their inclusion in the study.  
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Cell isolation from peripheral blood 
PBMC were isolated by density gradient centrifugation using lymphocyte separation medium 
(LSM 1077; PAA Laboratories, Pasching, Austria or Lymphoprep; AXIS-SHIELD, Oslo, 
Norway). PBMC were cryopreserved within 1 hour of isolation and stored in liquid nitrogen 
in medium containing 90% fetal bovine serum (lot 030M3399, Sigma-Aldrich, St. Louis, MO, 
USA) and 10% dimethyl sulfoxide (Sigma-Aldrich).  
 
Ex vivo immune cell subset staining  
The immune cell subsets and phenotypes that were determined are shown in Supplementary 
Figure 1. The identification of CD4+ T cells, CD8+ T cells, 
CD4+CD45RO+CD25+CD127
low
 regulatory T cells (Tregs), γδ T cells, B cells, monocytes 
and NK cells was performed using an eight-colour extracellular staining panel 
(Supplementary Table I).  For the identification of cytokine-expressing cells, PBMC were 
stimulated for 3 hours with PMA (50 ng/ml) and ionomycin (750 ng/ml) (both from 
Sigma-Aldrich) in the presence of GolgiStop according to the manufacturer’s instructions 
(BD, Oxford, UK). The identification of IL-17, IFNγ, TNFα or IL-10 expressing cells within 
CD4+ T cells, CD8+ T cells, γδ T cells, or CD19+ B cells was facilitated by staining with a 
ten-colour intracellular cytokine staining panel (Supplementary Table II). Extracellular 
surface staining was performed using the following monoclonal antibodies: 
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PE-Cy7-conjugated anti-CD3 (clone UCHT1), PerCP-Cy5.5-conjugated anti-CD4 (clone 
SK3), APC-Cy7-conjugated anti-CD14 (clone HCD14), Brilliant Violet 605-conjugated 
anti-CD19 (clone HIB19), APC-conjugated anti-CD56 (clone HCD56), PE-conjugated 
anti-CD25 (clone M-A251), FITC-conjugated anti-CD127 (clone A019D5), 
APC-Cy7-conjugated anti-CD45RA (clone HI100), Pacific Blue-conjugated anti-CD45RO 
(clone UCHL1), APC-conjugated anti-CD54 (clone HCD54), Pacific Blue-conjugated 
anti-CD86 (clone IT2.2) (all from BioLegend, London, UK), PE-CF594-conjugated anti-CD8 
(clone RPA-T8), FITC-conjugated anti-γδ T-cell receptor (TCR) (clone 11F2), 
PerCP-Cy5.5-conjugated anti-HLA-DR (clone G46-6) (all from BD Biosciences, Oxford, 
UK), and PE-conjugated anti-CD40 (clone LOB7/6, AbD Serotec, Kidlington, UK). 
 
    For intracellular staining, following appropriate cell surface staining, cells were fixed 
with 2% paraformaldehyde and permeabilized with 0.5% saponin (Sigma) and stained 
intracellularly with Pacific Blue-conjugated anti-CD4 (clone SK3), Alexa Fluor 
488-conjugated anti-IL-10 (clone JES3-9D7), PE-conjugated anti-IL-17A (clone BL168), 
APC-conjugated anti-TNFα (clone MAb11), and PerCP-Cy5.5-conjugated anti-IFNγ (clone 
4S.B3) (all from BioLegend). For intranuclear staining, cells were extracellularly stained and 
fixed as described above followed by permeabilization with 1x FoxP3 Perm Buffer 
(BioLegend). Cells were then stained with Alexa Fluor 647–conjugated FoxP3 (clone 259D, 
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BioLegend). Cells were acquired by flow cytometry using a LSRFortessa (BD Biosciences, 
Franklin Lakes NJ, USA) and analysed using the FlowJo software (Tree Star, Ashland, OR). 
Cytometer settings were tracked over time using BD Biosciences Cytometer Setup and 
Tracking software to monitor cytometer performance of the LSRFortessa at the NIHR 
Biomedical Research Centre Flow Cytometry Core Facility in Guy’s Hospital . Viable single 
cells were identified using a LIVE/DEAD® Fixable Blue Dead Cell stain kit (Life 
technologies, Carlsbad, CA). 
 
Cytokine detection  
Serum samples were collected and stored at -80°C until further use. Serum cytokine levels 
were determined by Luminex assay (Bio-Plex Pro
TM
 Human Th17 Cytokine Assays, Bio-Rad 
Laboratories, CA, USA). 
 
Statistical analysis  
Values are expressed as mean with SEM. Data were tested for normality using D’Agostino & 
Pearson omnibus normality testing and where not normally distributed data were log10 
transformed prior to analysis (which provided normally distributed results). Comparisons 
between patients and healthy controls were made using one-way analysis of variance 
followed by Bonferroni’s multiple comparison test for parametric data. Data were analysed 
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using Prism version 5 (GraphPad Software Inc, La Jolla, USA). For all tests, p values of less 
than 0.05 were considered significant. In addition, to allow for the possibility that variations 
in subject age might account for some of the differences seen, we carried out a bivariate 
linear regression analysis with diagnosis and age inputted as explanatory variables. This was 
analysed using SPSS v23 (IBM).  
 
Results 
Similar frequencies of major immune cell subsets in peripheral blood from patients 
with periodontal disease vs. periodontally healthy subjects 
To determine the frequencies of the major immune cell subsets, we applied the staining panel 
as described in Supplementary Table I to cryopreserved cells from patients with chronic 
periodontitis, aggressive periodontitis and periodontally healthy donors. We found no 
statistically significant differences in the frequencies of CD4+, CD8+ and γδ T cell subsets, 
or in CD19+ B cells, CD14+ monocytes and CD56+ NK cells in peripheral blood between 
the three groups (Figure 1). Frequencies of CD45RA+ or CD45RO+ cells within CD4+ T 
cell populations were also similar in the peripheral blood from the different groups (Figure 
2A and data not shown).  
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    Regarding Tregs, as expected [18] there was a slightly higher percentage of 
CD25+CD127
low
 T cells within the CD4+CD45RO+ T cell population (on average 10%) 
when compared to CD4+CD45RA+ or total CD4+ T cells (on average 5% and 7%, 
respectively), but the frequencies between the groups were not statistically significant 
different (Figure 2B and data not shown). No significant difference was observed in FOXP3 
expression in CD4+CD45RO+CD25+CD127
low
 regulatory T cells between the groups 
(Figure 2C). 
 
CD14+ monocytes from PB of patients with periodontal disease and healthy control 
subjects are phenotypically similar 
We investigated the phenotype of CD14+ monocytes from peripheral blood of patients with 
periodontal disease vs. healthy control subjects. No significant differences in the expression 
of the markers CD14, CD16, CD40, CD54, CD86 or HLA-DR by peripheral blood CD14+ 
monocytes were observed among the different groups (Figure 3). We also investigated the 
frequency and phenotype (expression of the markers CD14, CD16, CD40, CD54, CD86 or 
HLA-DR) of CD14+CD16+ monocytes in PB (often referred to as ‘inflammatory’ monocytes 
[19]) but no significant differences were found between the groups (data not shown). The 
frequencies of CD14+CD16+ monocytes in the healthy control, chronic and aggressive 
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periodontitis groups were also not significantly different (median 10.3% [IQR: 3, 24]; 4.2% 
[IQR: 3, 16]; 4.9% [IQR: 2, 28]; and 7.5% [IQR: 3, 25], respectively).  
 
Similar frequencies of cytokine producing cells within T cell populations from PB of 
patients with periodontal disease and healthy control subjects  
Next, we investigated whether there were quantitative differences in cytokine producing 
CD4+ T cells in peripheral blood between the groups (Figure 4A). In peripheral blood from 
patients with chronic periodontitis, on average 1±0.1% of the CD4+ T cells expressed IL-17, 
12±2.3% expressed IFNγ, a higher proportion expressed TNFα (on average 41±3.8%), and a 
very low proportion expressed anti-inflammatory IL-10 (on average 0.3±0.04%). However, 
these frequencies were not significantly different from patients with aggressive periodontitis, 
or periodontally healthy control subjects (Figure 4B).  
 
 In addition to the CD4+ T cell population, on average 0.4±0.01% of the CD8+ T cells 
expressed IL-17, 33±4% expressed IFNγ, 36±4% expressed TNFα, and a very low proportion 
expressed anti-inflammatory cytokine IL-10 (on average 0.1±0.01%) in peripheral blood from 
patients with chronic periodontitis. In the γδ T cell population in PB from patients with chronic 
periodontitis, on average 0.7±0.1% expressed IL-17, 52±6% expressed IFNγ, and 52±4% 
expressed TNFα (IL-10 expression was not measured in  T cells). However, as for CD4+ T 
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cells, there were no significant differences between the groups (Figure 5A, B and data not 
shown). Very few CD19+ B cells expressed IL-17, IFNγ or IL-10, whilst a small proportion 
expressed TNFα (on average 15±3% in chronic periodontitis) but this was not significantly 
different between groups.  
 
As chronic and aggressive periodontitis occur at different ages, and age itself may affect 
immune responses, we also carried out regression analysis to correct effects of disease 
diagnosis for age. The results are shown in Supplementary Table III and show that age had a 
significant effect only on %γδ TCR+ cells and CD40 MFI. There were no significant 
differences with periodontal diagnoses in all tests with the exception of %γδ TCR+IFNγ+, 
which was significantly higher in healthy subjects compared to either aggressive or chronic 
periodontitis subjects. 
 
Detection of T cell-derived and monocyte-derived mediators in serum 
Finally, we determined the levels of CD4+ T helper cell-derived (IFNγ, IL-4, IL-10, IL-17A, 
IL-17F, IL-21, IL-22, IL-25, TNFα) and monocyte-derived (IL-1β, IL-6, IL-10, IL-23, IL-33 
and TNFα) mediators in the sera of the aforementioned groups by Luminex assay. Protein 
levels of IFNγ, IL-1β, IL-17A, IL-21, IL-22, IL-23 and IL-25 (IL-17E) were below the lower 
detection limit of the Luminex assay in the majority of samples. IL-4, IL-6, IL-10, IL-17F, 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
IL-33 and TNFα were detectable in most serum samples, however no statistically significant 
differences between the groups were observed (Figure 6 and data not shown). 
 
Discussion 
In this study on newly diagnosed patients with chronic or aggressive periodontitis, we found 
no significant differences in the frequencies of major immune cell populations (CD4+ T cells, 
CD8+ T cells, Tregs, CD19+ B cells, CD14+ monocytes, CD56+ NK cells) and cytokine 
producing cells (IL-17, IFNγ, TNFα and IL-10 producing cells within CD4+ T cells, CD8+ T 
cells, γδ T cells and CD19+ B cells), nor in the phenotype of CD14+ monocytes from the 
peripheral blood of chronic and aggressive periodontitis patient cohorts when compared to 
healthy controls. 
     
    Conflicting data have been reported regarding the frequencies of cytokine-producing 
CD4+ T cells in periodontitis. A previous study reported a higher percentage of IL-4 
producing CD4+ T cells in PBMC from patients with chronic periodontitis vs. healthy 
controls, a higher percentage of TNFα producing CD4+ T cells in PBMC from patients with 
aggressive periodontitis vs. healthy controls, and no differences in the percentages of IFNγ or 
IL-10 producing CD4+ T cells between groups [8]. The authors suggested that CD4+ T cells 
from patients with chronic periodontitis are more committed to IL-4 production, whilst CD4+ 
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T cells from acute periodontitis are more committed to TNFα production; they did not 
measure the IL-17 producing CD4+ T cells in PBMC [8]. Schmidt and colleagues reported 
slightly higher percentages of IFNγ and IL-4 producing CD4+ T cells in PBMC from chronic 
vs. aggressive periodontitis and healthy controls, and no differences in the percentages of 
IL-17 producing CD4+ T cells among the three groups [9]. The authors also reported a 
slightly reduced Th1 response in patients with acute periodontitis defined by a lower Th1/Th2 
ratio when compared with chronic periodontitis and healthy controls [9]. Chen and colleagues 
recently reported significantly increased levels of IL-17A+ and IFNγ+ CD4+ T cells in 
PBMC from chronic periodontitis vs. healthy controls [10]. Our data however show that 
CD4+ T cells from chronic or aggressive periodontitis patients did not contain significantly 
enhanced percentages of IL-17+, IFNγ+, or TNF+ cells compared to age-and sex matched 
healthy controls. 
 
In terms of serum cytokine levels, previous studies have shown higher levels of IL-17 
and IL-1β in serum from patients with periodontitis when compared to healthy controls [2-4, 
20]. In these studies, Gϋmϋs et al. reported the serum IL-1β levels in chronic and aggressive 
periodontitis groups were higher than those in healthy control group, whilst no significant 
differences in serum IL-1β levels between the periodontitis groups were noted [20]. A 
different study however, reported no differences in the serum level of IL-1β between chronic 
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periodontitis and healthy control groups [21]. In our dataset, the serum levels of IL-17A and 
IL-1β were below the lower detection limit of the Luminex assay in the majority of samples. 
We did detect IL-4, IL-6, IL-10, IL-17F, IL-33 and TNFα however no statistically significant 
differences were found between the groups. Our data on IL-4, IL-6, IL-10 and TNFα data are 
in line with several previously published papers [6, 21, 22] although significant differences in 
serum cytokines between healthy controls, aggressive and chronic periodontitis have been 
reported [6, 22-24]. 
 
    Explanations for the differences in results between these studies are not immediately 
clear. Although there are some variations in study design, most particular in differences in 
periodontal case definitions and in ages between groups in some of these studies, it seems 
unlikely that these account for the observed differences. Differences in experimental and 
technical approaches and standardisation may explain some of these differences. In our study, 
to minimize inter-experimental variation, cryopreserved samples were analysed in batches of 
five different samples that always consisted of a mix of HC (n=1-2), CP (n=1-2) and AP 
(n=1-2); we also applied CS&T settings to monitor and correct for flow cytometer 
performance over time. Furthermore, in addition to analysing cytokine-expressing CD4+ T 
cells, we also analysed cytokine-expressing CD8+ T cells,  T cells and B cells, and 
Foxp3-expressing Tregs. Recently, CD8+ T cells and  T cells have been reported to be able 
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to produce IL-17 [25, 26] and B cells have been reported as a major source of IL-17A and 
IL-17F during Trypanosoma cruzi infection [27]. However, we did not detect significant 
differences in the frequencies of any of these cell populations between groups. Furthermore, 
the data were not only not different between groups but were also remarkably similar 
between groups. In a retrospective Power calculation using the data we obtained in our 
results, we found that our study had 96% Power to detect a mean increase of 50% in TNF+ 
cells with alpha as 0.05, and 74% Power to detect a similar change in IFNγ+ cells. Thus, we 
can reasonably rule out the likelihood of a type II error in failing to detect a difference that 
actually existed.  
 
    Previous studies have suggested a role for monocytes from patients with periodontitis in 
aortic inflammation [11, 12]. These data suggested that monocytes during or after periodontal 
pathogen challenge could contribute to inflammation in periodontitis-associated systemic 
disease. In addition, we recently showed that in the presence of Porphyromonas gingivalis 
significantly higher IL-17 production was observed in anti-CD3 mAb-stimulated 
monocyte/CD4+ T cell co-cultures from patients with periodontitis compared to periodontally 
healthy controls [28]. However, our current analysis did not reveal a significant difference in 
the frequencies of monocytes or expression of activation markers on monocytes among 
patients with different periodontal diseases and periodontally healthy controls.  
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    Our data do not exclude the possibility that differences in immune cell subsets are 
present at the site of inflammation in chronic and/or acute periodontitis vs. healthy gingival 
tissue. Indeed, studies have reported an increased percentage of IL-17-producing cells in 
gingival tissue from chronic periodontitis [28-30]. Furthermore, in our study we only 
determined relative proportions of immune cell subsets in PBMC and therefore we cannot 
rule out differences in absolute numbers of these immune cell types. 
 
    In conclusion, our data provide evidence that no significant alterations are present in the 
frequencies of major immune cell populations and cytokine producing cells in peripheral 
blood from patients with well-defined periodontal disease.  
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Table I. Demographic and clinical characteristics of the study subjects 
 
 HC 
(n=13) 
CP 
(n=15) 
AP 
(n=15) 
ANOVA 
p-value
a
  
Age, mean years (range) 36.8 (20-63) 42.1 (36-58)
#
 30.5 (19-36)
#
 P<0.001 
Gender 
Male, n (%) 6 (46)  7 (47) 8 (53) ns 
Female, n (%) 7 (54) 8 (53) 7 (47) ns 
Number of teeth, mean 28.7 28.1 28.7 ns 
PPD, mean ± SD mm 1.73 ± 0.24 3.53 ± 0.69
***
 3.19 ± 0.78
***
 P<0.0001 
BOP, mean ± SD % 10.9 ± 7.0 32.1 ± 14.9
*
 34.2 ± 30.9
**
 P<0.01 
% sites of PPD > 5 mm 0 ± 0 29.5 ± 12.8
***
 23.4 ± 16.6
***
 P<0.0001 
PISA, median (IQR) mm
2
 91 (42-136) 643 (337-906)
***
 255 (137-1336)
***
 P<0.0001 
AP, aggressive periodontitis patients; BOP, bleeding on probing; CP, chronic periodontitis patients; GI, 
gingivitis patients; HC, periodontally healthy controls; PISA, periodontal inflamed surface area; PPD, 
probing pocket depth. Data were tested for normality using D’Agostino & Pearson omnibus normality 
testing and where not normally distributed data were log10 transformed prior to analysis. Data were 
analysed by one-way ANOVA and the overall p-value shown as 
a
. Individual groups were compared to 
HC values by Bonferroni’s multiple comparison test for parametric data, and significant differences 
indicated as *, P<0.05; **, P<0.01; ***, P<0.001. Significant differences between CP and AP groups are 
indicated as 
# 
P<0.05. 
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Figure legends 
Figure 1. Frequencies of major immune cell populations in PBMC from healthy controls 
and patients with periodontal disease. PBMC were isolated from peripheral blood from 
patients with chronic periodontitis (CP, n=15) or aggressive periodontitis (AP, n=15) as well as 
periodontally healthy controls (HC, n=13). (A) Representative gating strategy and (B) 
cumulative data showing the frequencies of cell populations within live-gated single cells. 
Each symbol represents an individual donor. Lines show the mean with SEM. Log-transformed 
data were analysed by one-way analysis of variance followed by Bonferroni’s multiple 
comparison test.  
 
Figure 2. Frequencies of CD4+ CD45RO+ CD25+ CD127
low
 regulatory T cells in PBMC 
from healthy controls and patients with periodontal disease. PBMC were isolated from 
peripheral blood from patients with chronic periodontitis (CP, n=15) or aggressive 
periodontitis (AP, n=15) as well as periodontally healthy controls (HC, n=13). Cells were 
surface stained and then permeabilised and intranuclearly stained for FOXP3. Representative 
dot plots and cumulative data showing the frequencies of CD4+CD45RO+ T cells (A) and 
CD25+CD127
low
 cells within CD4+CD45RO+ T cells (B). (C) Representative histogram plots 
showing the expression levels of FOXP3 in CD4+CD25+CD127
low
 T cells. Each symbol 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
represents an individual donor. Lines show the mean with SEM. Log-transformed data were 
analysed by one-way analysis of variance with Bonferroni’s multiple comparison test.  
 
Figure 3. Expression of activation markers on CD14+ monocytes from healthy controls 
and patients with periodontal disease. PBMC were isolated from peripheral blood from 
patients with chronic periodontitis (CP, n=12) or aggressive periodontitis (AP, n=11) as well 
as periodontally healthy controls (HC, n=8). (A) Representative gating strategy to identify 
CD14+ monocytes. (B) Representative histogram plots and (C) cumulative data showing the 
geometric mean fluorescence intensity (MFI) for the surface expression of indicated markers 
determined by flow cytometry on CD14+ monocytes. Each symbol represents an individual 
donor. Lines show the mean with SEM. Log-transformed data were analysed by one-way 
analysis of variance with Bonferroni’s multiple comparison test.  
 
Figure 4. Frequencies of cytokine producing CD4+ T cells in PBMC from healthy 
controls and patients with periodontal disease. PBMC were isolated from peripheral blood 
from patients with chronic periodontitis (CP, n=15) or aggressive periodontitis (AP, n=15) as 
well as periodontally healthy controls (HC, n=13). Cells were stimulated ex vivo with PMA 
and ionomycin for 3 hours prior to intracellular cytokine staining. (A) Representative gating 
strategy and (B) cumulative data showing the frequencies for the IL-17, IFNγ, TNFα and 
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IL-10-expressing cells within CD4+ T cells as determined based on fluorescence-minus-one 
(FMO) control. Each symbol represents an individual donor. Lines show the mean with SEM. 
Log-transformed data were analysed by one-way analysis of variance with Bonferroni’s 
multiple comparison test. 
 
Figure 5. Frequencies of cytokine producing cells CD8+ and γδ T cells in PBMC from 
healthy controls and patients with periodontal disease. PBMC were isolated from 
peripheral blood from patients with chronic periodontitis (CP, n=15) or aggressive 
periodontitis (AP, n=15) as well as periodontally healthy controls (HC, n=13). (A, B) 
Representative dot plots and cumulative data for the frequencies of IL-17+, IFNγ+ and 
TNF+ cells within CD8+ T cells (A) or γδ T cells (B). Each symbol represents an individual 
donor. Lines show the mean with SEM. Log-transformed data were analysed by one-way 
analysis of variance with Bonferroni’s multiple comparison test. 
 
Figure 6. Cytokine levels in serum from patients with periodontitis or gingivitis, or from 
healthy controls. Serum from patients with chronic periodontitis (n=15) or aggressive 
periodontitis (n=15) as well as periodontally healthy controls (n=13) was analysed. Cytokine 
levels in 25 µl of serum were determined by Luminex. Each symbol represents an individual 
subject; the median and interquartile range is shown, dotted lines indicate the minimum 
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detectable concentration of that particular mediator. Log-transformed data were analysed by 
one-way analysis of variance with Bonferroni’s multiple comparison test. *P<0.05. 
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